Cresset Biomolecular Discovery Limited
Business and domestic software development · Litlington
ActiveUnited KingdomIncorporated 2001Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2022-03-31
IXBRL · 168 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 168 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 124
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0111_04151475_20220331
- Source archive
- Accounts_Monthly_Data-October2022.zip
Registered details
04151475- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2001-01-31
- Jurisdiction
- —
- Registered office
- NEW CAMBRIDGE HOUSE, BASSINGBOURN ROAD, LITLINGTON, CAMBRIDGESHIRE, SG8 0SS
Classification
2 SIC codes6201272190
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2022-09-12
£232,213 raised
£357,463 estimated post-money
Research and innovation
17 matched grantsSupporting the OpenMM Community-led Development of Next-Generation Condensed Matter Modelling SoftwareEPSRC · Research Grant · 2022-11-01 – 2026-01-21 · with 4 other participants£464,870whole project
Supporting the OpenMM Community-led Development of Next-Generation Condensed Matter Modelling Software
EPSRC · Research Grant · 2022-11-01 – 2026-01-21 · with 4 other participants
£464,870
whole project
University Of EdinburghleadCcp5CCP-BiosimCresset BioMolecular Discovery LtdStanford University
Modelling protein covalent modifications with molecular simulation and machine learningActiveEPSRC · Studentship · 2022-08-31 – 2026-08-30 · with 1 other participant£0whole project
Modelling protein covalent modifications with molecular simulation and machine learningActive
EPSRC · Studentship · 2022-08-31 – 2026-08-30 · with 1 other participant
£0
whole project
University Of EdinburghleadCresset BioMolecular Discovery Ltd
Next generation atomistic modelling for medicinal chemistry and biologyUKRI FLF · Fellowship · 2020-09-30 – 2024-09-29 · with 7 other participants£1,055,868whole project
Next generation atomistic modelling for medicinal chemistry and biology
UKRI FLF · Fellowship · 2020-09-30 – 2024-09-29 · with 7 other participants
£1,055,868
whole project
Newcastle UniversityleadAI-driven Structure-enabled Antiviral PlatformAstraZenecaCresset BioMolecular Discovery LtdIntellegensKuanoPhoremostSilicon Therapeutics
Next generation atomistic modelling for medicinal chemistry and biologyUKRI FLF · Fellowship · 2020-09-30 – 2024-09-29 · with 7 other participants£1,055,868whole project
Next generation atomistic modelling for medicinal chemistry and biology
UKRI FLF · Fellowship · 2020-09-30 – 2024-09-29 · with 7 other participants
£1,055,868
whole project
Newcastle UniversityleadAI-driven Structure-enabled Antiviral PlatformAstraZenecaCresset BioMolecular Discovery LtdIntellegensKuanoPhoremostSilicon Therapeutics
University of Edinburgh and Cresset BioMolecular Discovery LimitedInnovate UK · Knowledge Transfer Partnership · 2018-09-01 – 2019-11-30 · with 1 other participant
University of Edinburgh and Cresset BioMolecular Discovery Limited
Innovate UK · Knowledge Transfer Partnership · 2018-09-01 – 2019-11-30 · with 1 other participant
University of Edinburghlead£65,296
Cresset BioMolecular Discovery Limited—
Advancing structure-based drug design with novel binding free-energy calculations methodsEPSRC · Studentship · 2018-08-31 – 2022-08-30 · with 1 other participant£0whole project
Advancing structure-based drug design with novel binding free-energy calculations methods
EPSRC · Studentship · 2018-08-31 – 2022-08-30 · with 1 other participant
£0
whole project
University Of EdinburghleadCresset BioMolecular Discovery Ltd
Drug repositioning: in silico platform to study Drug-Protein relationshipsBBSRC · Studentship · 2017-09-30 – 2021-09-29 · with 1 other participant£0whole project
Drug repositioning: in silico platform to study Drug-Protein relationships
BBSRC · Studentship · 2017-09-30 – 2021-09-29 · with 1 other participant
£0
whole project
University College LondonleadCresset BioMolecular Discovery Ltd
Drug repositioning: in silico platform to study Drug-Protein relationshipsCOVID · Studentship · 2017-09-30 – 2022-03-29 · with 1 other participant£0whole project
Drug repositioning: in silico platform to study Drug-Protein relationships
COVID · Studentship · 2017-09-30 – 2022-03-29 · with 1 other participant
£0
whole project
University College LondonleadCresset BioMolecular Discovery Ltd
EPSRC Flagship Software - BioSimSpace: A shared space for the community development of biomolecular simulation workflowsEPSRC · Research Grant · 2017-08-06 – 2020-02-06 · with 7 other participants£523,962whole project
EPSRC Flagship Software - BioSimSpace: A shared space for the community development of biomolecular simulation workflows
EPSRC · Research Grant · 2017-08-06 – 2020-02-06 · with 7 other participants
£523,962
whole project
University Of EdinburghleadCresset BioMolecular Discovery LtdDrug Design Data ResourceEvotec (UK) LtdMemorial Sloan- Kettering Cancer CentreMolecular Science Software InstituteSyngentaUniversity of Colorado Boulder
Real time, collaborative 3D molecule design for preclinical drug discoveryLead
Innovate UK · Feasibility Studies · 2017-07-01 – 2018-02-28
£66,896
awarded
Sustainable RSE Careers for Sustainable Software DevelopmentEPSRC · Fellowship · 2016-07-03 – 2021-07-02 · with 2 other participants£488,452whole project
Sustainable RSE Careers for Sustainable Software Development
EPSRC · Fellowship · 2016-07-03 – 2021-07-02 · with 2 other participants
£488,452
whole project
A prototype of a new type of software application that uses cutting edge IT & science to enable the rational structure-based design of new compounds for pharmaceutical R&DLead
Innovate UK · GRD Development of Prototype · 2016-04-01 – 2017-02-28
£136,098
awarded
Market research to validate the commercial potential for a novel application that connects a multi-platform GUI to cloud-based infrastructure, to enable the rational structurebased design of new compounds for pharmaceutical R&DLead
Innovate UK · GRD Proof of Market · 2015-10-01 – 2015-12-31
£25,000
awarded
Market research to validate the commercial potential for a novel cloud-based application to enable medicinal chemists to rationally design new compounds for pharmaceutical R&D.Lead
Innovate UK · GRD Proof of Market · 2015-05-01 – 2015-10-31
£25,000
awarded
Demonstrating an innovative End-to-End Drug Discovery (E2D2) platformInnovate UK · Collaborative R&D · 2012-08-01 – 2014-10-31 · with 2 other participants£179,345awarded
Demonstrating an innovative End-to-End Drug Discovery (E2D2) platform
Innovate UK · Collaborative R&D · 2012-08-01 – 2014-10-31 · with 2 other participants
£179,345
awarded
Cresset BioMolecular Discovery Limited£179,345
University of Bristol And Cresset BioMolecular Discovery LimitedInnovate UK · Knowledge Transfer Partnership · 2012-02-01 – 2013-08-31 · with 1 other participant
University of Bristol And Cresset BioMolecular Discovery Limited
Innovate UK · Knowledge Transfer Partnership · 2012-02-01 – 2013-08-31 · with 1 other participant
University of Bristollead£65,069
Cresset BioMolecular Discovery Limited—
Exploiting data for drug reprofilingLeadInnovate UK · Collaborative R&D · 2011-08-01 – 2012-09-30 · with 1 other participant£208,850awarded
Exploiting data for drug reprofilingLead
Innovate UK · Collaborative R&D · 2011-08-01 – 2012-09-30 · with 1 other participant
£208,850
awarded
Cresset BioMolecular Discovery Limitedlead£208,850